Skip to content

Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation

Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06951100
Acronym
Mi-AF
Enrollment
300
Registered
2025-04-30
Start date
2025-05-01
Completion date
2029-10-31
Last updated
2025-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation (AF)

Keywords

Atrial Fibrillation, Cardiology, Emergency Medicine, Myocardial Infarction, Myocardial Ischemia, Coronary Artery Disease

Brief summary

The goal of this observational study is to better understand the role of measuring troponin (a protein measured by a blood test) and coronary imaging in patients presenting with rapid atrial fibrillation (AF) The main questions this study aims to answer are: 1. Are patients with a fast, irregular heartbeat (rapid AF) and damage to the heart (myocardial injury) more likely than those without damage to the heart to have blocked heart arteries (obstructive coronary artery disease) 2. Are patients with a fast, irregular heartbeat (rapid AF) and damage to the heart (myocardial injury) with further evidence that their heart hasn't been getting enough oxygen (myocardial ischemia) more likely to have imaging evidence of myocardial infarction than those without myocardial ischemia To do this, we will measure troponin in patients with rapid AF and then carry out further investigations of the heart (electrocardiogram, echocardiogram, CT scan and cardiac MRI)

Interventions

To assess the presence of obstructive coronary artery disease, participants will either have coronary angiography as part of their routine care or they will return for a research CT scan of their heart (CT Coronary Angiogram)

Sponsors

British Heart Foundation
CollaboratorOTHER
NHS Lothian
CollaboratorOTHER_GOV
University of Edinburgh
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 years and over 2. Primary presentation with symptoms related to atrial fibrillation 3. Atrial fibrillation with a ventricular rate \>100 bpm on a 12-lead electrocardiogram 4. Able to provide informed consent

Exclusion criteria

1. Previous myocardial infarction 2. Previous coronary revascularisation procedure 3. Patients in renal failure (eGFR \<30ml/min/1.73m2) or major allergy to contrast media 4. Pregnancy or breast feeding 5. Deemed unsuitable for participation in the study by the attending clinician 6. Previous enrolment in the trial

Design outcomes

Primary

MeasureTime frameDescription
Presence of obstructive coronary artery diseasewithin 4 weeks of presentationPresence of obstructive coronary artery disease as defined as at least one stenosis ≥70% in a major epicardial coronary artery or ≥50% in the left main stem on CTCA or invasive coronary angiography

Secondary

MeasureTime frameDescription
Imaging evidence of new myocardial infarctionwithin 4 weeks of presentationImaging evidence of new myocardial infarction

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026